ABCM | Abcam plc

Healthcare | Biotechnology | United Kingdom | NASD

Index	-	P/E	-	EPS (ttm)	-0.05	Insider Own	6.55%	Shs Outstand	228.80M	Perf Week	3.62%
Market Cap	3.47B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	214.54M	Perf Month	-3.70%
Income	-10.60M	PEG	-	EPS next Q	-	Inst Own	14.40%	Short Float / Ratio	0.28% / 0.75	Perf Quarter	9.81%
Sales	453.00M	P/S	7.67	EPS this Y	-148.90%	Inst Trans	15.09%	Short Interest	0.60M	Perf Half Y	5.36%
Book/sh	3.98	P/B	4.25	EPS next Y	-	ROA	-0.90%	Target Price	19.92	Perf Year	13.42%
Cash/sh	0.54	P/C	31.14	EPS next 5Y	0.39%	ROE	-1.20%	52W Range	12.48 - 18.38	Perf YTD	8.61%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-0.30%	52W High	-8.05%	Beta	-
Dividend %	-	Quick Ratio	0.90	Sales past 5Y	-	Gross Margin	74.80%	52W Low	35.42%	ATR	0.70
Employees	1800	Current Ratio	1.30	Sales Q/Q	19.70%	Oper. Margin	-2.80%	RSI (14)	56.00	Volatility	3.96% 4.40%
Optionable	Yes	Debt/Eq	0.31	EPS Q/Q	-207.00%	Profit Margin	-2.40%	Rel Volume	1.68	Prev Close	16.25
Shortable	Yes	LT Debt/Eq	0.13	Earnings	Mar 20 BMO	Payout	-	Avg Volume	800.84K	Price	16.90
Recom	2.30	SMA20	-0.51%	SMA50	8.82%	SMA200	9.70%	Volume	1,344,298	Change	4.00%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-14-22	Initiated	Deutsche Bank	Hold	$15
Nov-16-20	Initiated	Morgan Stanley	Equal-Weight	$21

May-30-23 04:30PM	ABCAM PLC: Statement on calling an Extraordinary General Meeting (PR Newswire)
May-23-23 09:55AM	How Much Upside is Left in Abcam PLC Sponsored ADR (ABCM)? Wall Street Analysts Think 27.55% (Zacks)
May-17-23 09:18AM	ABCAM PLC Result of Annual General Meeting (PR Newswire)
May-11-23 11:45AM	Abcam Founder Ramps Up Board Seat Push at $4 Billion Biotech (Bloomberg)
07:05AM	Abcam Founder Pushes for Better Performance at Biotech (Bloomberg)
04:30PM	Loading…
May-04-23 04:30PM	Abcam, plc Business Update (PR Newswire)
May-01-23 06:00PM	ABCAM PLC Comments on Investor Engagement (PR Newswire) +6.14%
Apr-17-23 07:00AM	ABCAM PLC: Upcoming Abcam Investor Events (PR Newswire)
Apr-13-23 04:15PM	ABCAM PLC: Trading Update (PR Newswire)
Mar-30-23 07:00AM	Abcam, plc Publication of 2022 Annual Report and Accounts and Notice of Annual General Meeting (PR Newswire)
Mar-20-23 07:05AM	ABCAM PLC: Final results for the year ended 31 December 2022 (PR Newswire)
Mar-10-23 08:00AM	Abcam to Report Full Year Results on Monday, March 20, 2023 (PR Newswire) -6.75%
Jan-30-23 08:00AM	ABCAM PLC: Trading Update (PR Newswire) -15.46%
Dec-27-22 04:58PM	A biotechnology product supplier is shuttering its office in Milpitas and cutting 30 workers (American City Business Journals)
Dec-12-22 09:53AM	10 Best Medical Stocks Under $20 (Insider Monkey)
03:20AM	Loading…
03:20AM	Abcam plc: Update on AIM Delisting (PR Newswire)
Nov-16-22 05:09PM	Is Abcam the Perfect Nasdaq Stock? (GuruFocus.com)
Nov-11-22 10:30AM	ABCAM PLC: Result of General Meeting - Shareholders approve AIM Delisting (PR Newswire)
Nov-09-22 06:00AM	NanoString and Abcam Expand Collaboration to Advance Spatial Multiomics Research (Business Wire)
Oct-17-22 02:00AM	ABCAM PLC: Proposed resolution for cancellation of AIM listing (PR Newswire)
Oct-05-22 09:25AM	11 Cheap Healthcare Stocks To Invest In (Insider Monkey)
Sep-13-22 04:24AM	Cambridge biotech opts for Nasdaq listing over LSEs AIM (MarketWatch)
Sep-12-22 08:00AM	Edited Transcript of ABCA.L earnings conference call or presentation 12-Sep-22 12:00pm GMT (Thomson Reuters StreetEvents)
07:00AM	ABCAM PLC: Interim results for the six-month period ended 30 June 2022 (PR Newswire)
Jul-20-22 09:50AM	ABCAM PLC First Half Trading Update (PR Newswire) +6.05%
09:06AM	ABCAM PLC First Half Trading Update (CNW Group)
Jul-13-22 01:22AM	Great news for Abcam plc (LON:ABC): Insiders acquired stock in large numbers last year (Simply Wall St.)
Jun-27-22 02:00AM	Abcam: Appointment of Vice President of Investor Relations (PR Newswire)
02:00AM	Abcam: Appointment of Vice President of Investor Relations (CNW Group)
Jun-18-22 04:24AM	Abcam plc's (LON:ABC) Intrinsic Value Is Potentially 43% Above Its Share Price (Simply Wall St.)
05:35AM	Loading…
May-02-22 05:35AM	Are Abcam plc's (LON:ABC) Mixed Financials Driving The Negative Sentiment? (Simply Wall St.)
Mar-25-22 08:40AM	Abcam the most awarded company at 2022 industry awards (PR Newswire)
08:00AM	Abcam the most awarded company at 2022 industry awards (PR Newswire)
Mar-18-22 10:00AM	Wall Street Analysts Predict a 27% Upside in Abcam PLC Sponsored ADR (ABCM): Here's What You Should Know (Zacks)
Mar-14-22 08:00AM	Abcam Plc Results for the 12- and 18-month periods ended 31 December 2021 (GlobeNewswire)
Mar-10-22 04:46AM	Investing in Abcam (LON:ABC) five years ago would have delivered you a 38% gain (Simply Wall St.)
Feb-01-22 04:00AM	Abcam Collaborates With Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research Applications (Business Wire)
Jan-09-22 01:02AM	Is Abcam plc (LON:ABC) Trading At A 20% Discount? (Simply Wall St.)
Jan-04-22 04:00AM	Alamar Biosciences partners with Abcam to drive understanding of the human proteome (PR Newswire) -8.96%
04:00AM	Alamar Biosciences partners with Abcam to drive understanding of the human proteome (CNW Group)
Nov-09-21 11:16PM	Can Mixed Fundamentals Have A Negative Impact on Abcam plc (LON:ABC) Current Share Price Momentum? (Simply Wall St.)
Nov-02-21 08:00AM	Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome (GlobeNewswire)
08:00AM	Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome (CNW Group)
Oct-27-21 02:00AM	Abcam completes $340m strategic acquisition and expands kit capacity and capability (PR Newswire)
Sep-13-21 07:00AM	29% Constant Currency Revenue Growth in H2 as Lab Activity Gradually Recovers and Demand for Abcam In-house Products Increases (GlobeNewswire)
Aug-02-21 07:38AM	Abcam To Acquire Supplier BioVision For $340M In Cash (Benzinga)
02:00AM	Abcam to Acquire BioVision for $340 million (GlobeNewswire)
Jul-29-21 09:06AM	New Strong Sell Stocks for July 29th (Zacks)
Jul-13-21 12:44PM	Is Abcam plc (ABCM) A Smart Long-Term Buy? (Insider Monkey)
07:00AM	Abcam opens new US facility in Boston, MA (PR Newswire)
Jun-24-21 08:09PM	Some Shareholders May find It Hard To Increase Abcam plc's (LON:ABC) CEO Compensation This Year (Simply Wall St.)
Jun-22-21 08:00AM	Pionyr and Abcam extend partnership to evaluate TREM2-expressing cells in cancer patients (PR Newswire)
May-29-21 06:33AM	2 of the Safest Biotech Stocks You'll Find Today (Motley Fool)
May-24-21 02:59AM	Abcam plc (LON:ABC) Insiders Increased Their Holdings (Simply Wall St.)
Apr-12-21 05:00AM	Abcam and MEDx extend precision medicine strategic partnership (GlobeNewswire)
Mar-24-21 07:49AM	Abcam Wins Industry Awards from CiteAb (GlobeNewswire)
Mar-08-21 11:15AM	Abcam Plc to Host Earnings Call (ACCESSWIRE) -6.68%
07:00AM	8.3% constant currency revenue growth in H1 as customers gradually return to labs (GlobeNewswire)
Mar-04-21 04:00AM	Abcam Expands Presence in China to Support Increased Demand of BioPharma Sector (GlobeNewswire)
Feb-26-21 02:00AM	Abcam to Report Interim Results on Monday, March 8, 2021 (GlobeNewswire)
Feb-17-21 07:00AM	Abcam to present at the 2021 SVB Leerink Global Healthcare Conference (GlobeNewswire)
Jan-28-21 07:08PM	Can You Imagine How Jubilant Abcam's (LON:ABC) Shareholders Feel About Its 164% Share Price Gain? (Simply Wall St.)
02:00AM	Abcam Plc Appointment of Non-Executive Directors (GlobeNewswire)
Jan-27-21 08:00AM	belairdirect Announces Continued Partnership with Breakfast Club of Canada with $1.5 Million Donation (CNW Group)
Jan-11-21 07:00AM	Abcam plc Half Year Trading Update (GlobeNewswire) +8.71%
Dec-08-20 07:00AM	Abcam reveals new cell engineering facility in Bay Area (PR Newswire)
Dec-05-20 08:03PM	Key Things To Understand About Abcam's (LON:ABC) CEO Pay Cheque (Simply Wall St.)
Nov-03-20 08:35AM	Abcam plc: Annual Report, Impact Report and Notice of AGM (GlobeNewswire)
08:30AM	Abcam plc: Consultation on 2020 LTIP Awards (GlobeNewswire)
Oct-26-20 11:45AM	Abcam Announces Closing of Offering (GlobeNewswire)

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABCM | Abcam plc

Upgrade your FINVIZ experience